News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Bitget UEX Daily | US-Iran Talks Remain Divided but Ceasefire Expectations Boost US Stocks; Google Releases Cache Compression Technology Impacting Storage Sector (March 26, 2026)2PDD Holdings 2025 Q4 Earnings: Growth Significantly Slows, Full Bet on Supply Chain Investment to Build the "New Pinduoduo"3Hard to go long, hard to go short! Nomura strategist: "Current macro volatility, trading poses career risks"; Goldman Sachs analyst: "Cash is king"

Buy shares of Zillow and Sprout Social as artificial intelligence transforms online services
101 finance·2026/03/26 20:00

CLS Model 1: The Liquidity Trap That Creates a 50% Reversal Trade or a Total Breakdown
101 finance·2026/03/26 19:57

CLS Settlement Clock: The 11pm London Cutoff That May Cause a T+1 Disruption by 2027
101 finance·2026/03/26 19:57

Bitcoin floor ‘near $70K’ as TradFi returns: Will war, inflation break their belief?
Cointelegraph·2026/03/26 19:57

ImmunityBio's Brink: 9% Drop Crushes Optimism While Bulls Endure Persistent Downward Force
101 finance·2026/03/26 19:54

Madrigal Surges 11.66%: A Volatile Breakout Defies Sector Stagnation as Bulls Test $572
101 finance·2026/03/26 19:54

Jianzhi Education Jumps 11% — With No Reason Why
101 finance·2026/03/26 19:48

Elemental Royalty Plummets 9% as Dividend Hopes Clash with Market Cold Snap
101 finance·2026/03/26 19:45

Dyadic International Drops Close to 20%: Technical Breakdown Hits 52-Week Low
101 finance·2026/03/26 19:42
Flash
20:06
Zenas BioPharma Inc. recently announced that the proceeds from its financing will be specifically used to support the commercialization preparations of its core product, Obexelimab, in the US market.In addition, part of the funds will also be used to further expand the company’s R&D pipeline, as well as for other general corporate operating purposes.
20:06
Wrap Technologies Inc. is accelerating its growth momentum and has set an ambitious goal of achieving 100% revenue growth by 2026.At the same time, the company announced its financial results for the fourth quarter and the entire fiscal year of 2025.
20:05
In a recent filing with the U.S. Securities and Exchange Commission, Riverview Bancorp Inc disclosed a significant asset disposal action.After completing its portfolio reclassification, the company has sold securities assets totaling 149.3 million USD, with a preliminary estimate of approximately 11.4 million USD in pre-tax losses. This transaction marks an important step in Riverview's strategic adjustment of its balance sheet. The decision to sell the securities arose from the company's prudent assessment of the current market environment and aims to optimize the asset allocation structure. Although this disposal results in short-term financial losses, it may create more favorable conditions for future capital flexibility and risk management. Market analysts point out that timely adjustments of securities portfolios by financial institutions are common risk management practices. By accepting controllable book losses, Riverview may be paving the way to mitigate interest rate fluctuations and enhance capital use efficiency. The specific details and subsequent impact of this transaction will be further clarified in the company's upcoming quarterly financial report.
News